Monashee Investment Management’s ASLAN Pharmaceuticals ASLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-10,500
Closed -$1.41M – 487
2021
Q1
$1.41M Buy
+10,500
New +$1.33M 0.22% 139

Other funds holding ASLN

Monashee Investment Management's ASLN Position: Q2 2021 in Review

Monashee Investment Management sold out of ASLAN Pharmaceuticals (ASLN) in Q2 2021, closing a stake of 10,500 shares — an estimated $1.41M sold.

Monashee Investment Management first reported a position in ASLN in Q1 2021 and held it in 1 quarter. The position peaked at $1.41M in Q1 2021. 31 funds tracked by Wall St. Rank hold ASLN as of Q2 2021.

  • Monashee Investment Management reported no remaining ASLAN Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Monashee Investment Management sold 10,500 ASLAN Pharmaceuticals shares in Q2 2021, an estimated $1.41M.
  • Monashee Investment Management first reported a position in ASLAN Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Monashee Investment Management's ASLAN Pharmaceuticals position peaked at $1.41M in Q1 2021.
  • 31 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals as of Q2 2021.

Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.